Loading provider…
Loading provider…
Radiation Oncology Physician in Ann Arbor, MI
NPI: 1740464627Primary Practice Location
UNIVERSITY OF MICHIGAN HEALTH SYSTEM
1540 E Hospital Dr, Ann Arbor, MI
Primary Employer
Regents of the University of Michigan
michiganmedicine.org
HQ Phone
Get MD Kyle's Phone NumberMobile
Get MD Kyle's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMI State Medical License
TN State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 77263Complex radiation therapy planning | 61 | 77 |
| 2 | 77427Radiation treatment management, 5 treatment sessions | 47 | 101 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 42 | 42 |
| 4 | 77300Calculation of radiation therapy dose | 39 | 151 |
| 5 | 77332Design and construction of simple radiation treatment device | 37 | 87 |
Role of Stereotactic Body Radiation Therapy in Oligometastatic Sarcoma.
Authors: @ValidYN, LastName, ForeName, Initials, AffiliationInfo
Journal: Cancer J
Salary and Resources Provided to Junior Faculty in Radiation Oncology.
Authors: Lalani, Nafisha, Griffith, Kent A, Jones, Rochelle D, Cuneo, Kyle, Jagsi, Reshma
Journal: Int J Radiat Oncol Biol Phys
Publication Date: 2018-09-18
Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After 90Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity.
Authors: Ravi Kaza, Matthew Cousins
Publication Date: 2021-04-16
Lead Sponsor: ECOG-ACRIN Cancer Research Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, OTHER: Fludeoxyglucose F-18, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, DRUG: Capecitabine, OTHER: Quality-of-Life Assessment, DRUG: Fluorouracil, RADIATION: Intensity-Modulated Radiation Therapy, PROCEDURE: Computed Tomography, PROCEDURE: Biopsy, DRUG: Mitomycin
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: BIOLOGICAL: Pembrolizumab, DRUG: Capecitabine, DRUG: Fluorouracil, DRUG: Veliparib, RADIATION: Intensity-Modulated Radiation Therapy, DRUG: Oxaliplatin, DRUG: Leucovorin
Lead Sponsor: University of Michigan Rogel Cancer Center
Collaborators: National Institutes of Health (NIH)
Intervention / Treatment: RADIATION: Adaptive Radiation Therapy